Intuitive Surgical (NASDAQ:ISRG) PT Lowered to $289.00 at Wells Fargo & Company

Intuitive Surgical (NASDAQ:ISRGGet Rating) had its price objective decreased by investment analysts at Wells Fargo & Company from $305.00 to $289.00 in a research note issued on Wednesday, The Fly reports. Wells Fargo & Company‘s price objective would indicate a potential upside of 12.02% from the stock’s current price.

A number of other brokerages have also issued reports on ISRG. Barclays increased their price objective on shares of Intuitive Surgical from $235.00 to $298.00 in a report on Wednesday, January 4th. Argus increased their target price on Intuitive Surgical from $265.00 to $320.00 and gave the company a “buy” rating in a research report on Thursday, December 22nd. Jefferies Financial Group began coverage on Intuitive Surgical in a research report on Wednesday, October 12th. They set a “hold” rating and a $210.00 target price for the company. Morgan Stanley increased their target price on Intuitive Surgical from $235.00 to $290.00 and gave the company an “equal weight” rating in a research report on Friday, January 6th. Finally, Piper Sandler increased their target price on Intuitive Surgical from $260.00 to $265.00 and gave the company an “overweight” rating in a research report on Wednesday, October 19th. Seven equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $278.74.

Intuitive Surgical Price Performance

Shares of ISRG opened at $257.98 on Wednesday. Intuitive Surgical has a 1 year low of $180.07 and a 1 year high of $308.97. The company has a 50 day simple moving average of $264.91 and a two-hundred day simple moving average of $234.18. The firm has a market cap of $91.17 billion, a P/E ratio of 68.07, a price-to-earnings-growth ratio of 4.90 and a beta of 1.36.

Intuitive Surgical (NASDAQ:ISRGGet Rating) last announced its quarterly earnings data on Tuesday, January 24th. The medical equipment provider reported $1.23 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.25 by ($0.02). Intuitive Surgical had a net margin of 22.52% and a return on equity of 11.54%. The company had revenue of $1.66 billion for the quarter, compared to analysts’ expectations of $1.66 billion. During the same period last year, the business earned $1.30 earnings per share. The company’s quarterly revenue was up 6.7% compared to the same quarter last year. On average, sell-side analysts anticipate that Intuitive Surgical will post 3.77 earnings per share for the current year.

Insider Activity

In other Intuitive Surgical news, EVP Myriam Curet sold 8,000 shares of Intuitive Surgical stock in a transaction dated Tuesday, November 1st. The stock was sold at an average price of $250.06, for a total value of $2,000,480.00. Following the transaction, the executive vice president now owns 217 shares in the company, valued at $54,263.02. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other Intuitive Surgical news, EVP Myriam Curet sold 8,000 shares of the firm’s stock in a transaction dated Tuesday, November 1st. The stock was sold at an average price of $250.06, for a total value of $2,000,480.00. Following the completion of the sale, the executive vice president now owns 217 shares of the company’s stock, valued at $54,263.02. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Amal M. Johnson sold 6,375 shares of Intuitive Surgical stock in a transaction dated Tuesday, November 8th. The stock was sold at an average price of $239.36, for a total value of $1,525,920.00. Following the sale, the director now directly owns 11,224 shares of the company’s stock, valued at approximately $2,686,576.64. The disclosure for this sale can be found here. Insiders own 0.90% of the company’s stock.

Institutional Trading of Intuitive Surgical

A number of institutional investors and hedge funds have recently made changes to their positions in ISRG. MADDEN SECURITIES Corp purchased a new stake in shares of Intuitive Surgical during the fourth quarter worth approximately $26,000. Evermay Wealth Management LLC grew its holdings in Intuitive Surgical by 103.4% in the 4th quarter. Evermay Wealth Management LLC now owns 118 shares of the medical equipment provider’s stock valued at $31,000 after buying an additional 60 shares in the last quarter. MinichMacGregor Wealth Management LLC purchased a new stake in Intuitive Surgical in the 4th quarter valued at $35,000. Fiduciary Alliance LLC acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at $38,000. Finally, Bogart Wealth LLC lifted its stake in shares of Intuitive Surgical by 70.1% in the 3rd quarter. Bogart Wealth LLC now owns 148 shares of the medical equipment provider’s stock valued at $28,000 after purchasing an additional 61 shares during the last quarter. 81.96% of the stock is currently owned by hedge funds and other institutional investors.

About Intuitive Surgical

(Get Rating)

Intuitive Surgical, Inc engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. Its products include Da Vinci and Ion. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

See Also

The Fly logo

Analyst Recommendations for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.